Survival of patients with squamous lung cancer after surgery varies from person to person and is related to the patient’s postoperative pathologic stage, molecular markers, coexisting disease, and care. Based…
Lung squamous carcinoma, also known as squamous epithelial cell carcinoma of the lung, including spindle cell carcinoma, is the most common type, accounting for 40% to 51% of primary lung…
Fever is a clinical symptom that may occur in many diseases, and many cancer patients will also have fever. This is because during the transition period when cancer cells are…
In recent years, with the advancement of molecular biology research, the survival of lung adenocarcinoma has been greatly prolonged due to the wide application of targeted therapy. However, there is…
The SQUIRE trial found that necitumumab combined with chemotherapy prolonged median overall survival (mOS) by 1.6 months (HR=0.84) in patients with metastatic squamous lung cancer, however the cost-benefit relationship for…
Among various malignant tumors, the incidence and mortality rate of lung cancer has steadily ranked the first and continues to rise. Among lung cancer patients, 85% of them have already…
Surgeons have long been interested in sublobar resection for non-small cell lung cancer (NSCLC). Preoperative prediction of lymph node metastases is essential for selecting the right patient for sublobar resection.…
Data from the LUX-Lung 8 trial demonstrated that afatinib significantly delayed disease progression (primary endpoint) and prolonged overall survival (key secondary endpoint) in patients with squamous cell carcinoma of the…
The main treatment for brain metastasis of non-small cell lung cancer is radiotherapy, which is determined by the control of extracranial lesions and the size and scope of intracranial lesions.…
The symptoms of lung squamous carcinoma in China are very complicated, and many patients diagnosed clinically do not know the early symptoms very well, and many patients are diagnosed with…